Oragenics, Inc. to Explore Strategic Alternatives for its OTC Probiotic Products Business
December 22, 2014 at 16:55 PM EST
Florida-based biopharmaceutical company Oragenics, Inc. (NYSE:MKT – OGEN) has announced today that its board of directors has authorized ...